With the ever-growing prevalence of drug-resistant pathogens, it has never been more important that we refresh the drug pipeline with new antimicrobials that act on new targets or exhibit novel modes of action. The rise of antimicrobial resistance and recent COVID pandemic serve to highlight the importance of developing effective treatments for infection, and is helping to drive a resurgence in anti-infectives drug discovery and the development of innovative technologies and approaches for combating infection through more effective detection and diagnosis methods.
This two-day symposium will examine the latest advances in anti-infectives drug discovery from a medicinal chemist’s perspective, focusing on the particular challenges associated with developing anti-infectives whilst also showcasing emerging strategies for tackling infection.
This meeting will bring together leading exponents in the field from academia and industry, so will appeal to anyone with an interest in antimicrobial resistance and anti-infectives drug discovery.
This two-day symposium will examine the latest advances in anti-infectives drug discovery from a medicinal chemist’s perspective, focusing on the particular challenges associated with developing anti-infectives whilst also showcasing emerging strategies for tackling infection.
This meeting will bring together leading exponents in the field from academia and industry, so will appeal to anyone with an interest in antimicrobial resistance and anti-infectives drug discovery.
